Evidence Hub

Elizabethkingia miricola mediastinitis and bacteraemia

Rothwell-Kelly G, Egan C, Schaffer K

BMJ case reports, 2025

Abstract

Elizabethkingia species, including Elizabethkingia miricola, are rare opportunistic Gram-negative bacteria. We present a case of E. miricola bloodstream infection associated with a polymicrobial mediastinitis. A male in his 70s underwent an elective Nissen fundoplication, deteriorated on day one post surgery and was transferred to the intensive care unit. Blood cultures revealed E. miricola A CT scan revealed an air and fluid collection posterior to the heart, moderate bilateral pleural effusions, an extensive pneumomediastinum, pockets of free air within the upper abdomen and a splenic infarct. A mediastinal drain and pleural drains were inserted, which cultured E. miricola, Candida albicans, Staphylococcus aureus and anaerobes. The patient was treated with piperacillin-tazobactam and fluconazole with a good response. E. miricola is intrinsically resistant to multiple antibiotic classes, including carbapenems and aminoglycosides. The lack of published cases combined with resistance makes management challenging. Our case highlighted the need for a combination of antibiotic therapy and source control.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free